Sandra L. Fenwick
Recently retired as CEO of Boston Children’s Hospital, Sandra L. Fenwick led Boston Children’s Hospital in advancing pediatric health care throughout the region and around the world, working to improve access to safe, quality care for all, and supporting the research and innovative partnerships required to lead the way in creating the future of care. She is a tireless advocate for equitable children’s health and has been instrumental in developing strategies that position Boston Children’s as the scientific and thought leader in pediatric health. Boston Children’s is a 415-bed Harvard teaching hospital with over $3B of revenues including $500M of research funding and 20,000 faculty and staff.
Sandra joined Boston Children’s in 1999, and was promoted to chief operating officer later that year. She added the title of president in 2008, and was named CEO in 2013. Prior to joining Boston Children’s, she worked for 20 years in operations, strategy and and business development at Beth Israel Hospital and CareGroup, Inc. She holds a Bachelor of Science, with distinction in biology and chemistry, from Simmons University and a Masters in Public Health from the University of Texas School of Public Health.
She currently serves on the Board of Directors of the Risk Management Foundation of the Harvard Medical Institutions, Inc, Harvard’s Wyss Institute for Biologically-inspired Engineering, Patient Discovery Solutions, Inc., Teladoc Health, Inc. and BCH UK Charity, Ltd. She is also a member of the International Women’s Forum/Massachusetts and Women Corporate Directors/Boston. She has received numerous awards for her contributions to healthcare and business including four honorary doctorates, the Greater Boston Chamber’s Pinnacle Award and was inducted into the Academy of Distinguished Bostonians. In 2021, she received the inaugural Helen Drinan Visionary Leadership Award from Simmons University.